Transfection of B7—1 cDNA empowers antigen presentation of blood malignant cells for activation of anti—tumor T cells
Ojbective To define roles of B7-1 co-stimulation factor expressed in human malignant cell lines in mediating anti-tumor T cell immune responses.Methods Examining human leucocyte antigen(HLA)and B7 expressions on 8 human blood malignancies cell lines by flow cytometry.Transtecting B7-1 gene to B7-1 n...
        Saved in:
      
    
          | Published in | Chinese medical journal Vol. 116; no. 1; pp. 78 - 84 | 
|---|---|
| Main Author | |
| Format | Journal Article | 
| Language | English | 
| Published | 
        China
          Department of Hematology, Third Hospital, Peking University, Beijing 100083, China%Institute of Blood Disease Research, People's Hospital, Peking University, Beijing 100083, China
    
        2003
     | 
| Subjects | |
| Online Access | Get full text | 
| ISSN | 0366-6999 2542-5641  | 
Cover
| Abstract | Ojbective To define roles of B7-1 co-stimulation factor expressed in human malignant cell lines in mediating anti-tumor T cell immune responses.Methods Examining human leucocyte antigen(HLA)and B7 expressions on 8 human blood malignancies cell lines by flow cytometry.Transtecting B7-1 gene to B7-1 negative(B7^-)Raji and B7^- Jurkat cell lines by liposome,and comparing the potencies of blood malignant cell lines in the induction of T cell activation by examination of T cell cytokine mRNAs before and after transtection using semi-quantitative reverse transcription polymerase chain reaction(RT-PCR). Results High level of HLA Ⅰ and Ⅱ molecules were expressed in most human blood malignant cell lines examined,and the co-stimulatory factor B7-2 was also highly expressed.In contrast,another member of B7 family:B7-1 was either not axpressed or very limitedly expressed in most of these hematopoietic malignant cell lines.Most importantly,transfection of B7-1 gene to B7^-.Raji and B7^-.Jurkat cell lines made these cell lines better antigen presenting cells for stimulation of anti-tumor T cell activation,which was demonstrated by up regulation of expression of T cell cytokines IL-2,IL-4 and INF-γ mRNAs after incubation of these tumor cells with T cells for 24h.Conclusions B7 co-stimulation plays an important role in anti-tumor immunity.Transfection of B7-1 gene to the human hematopoietic malignant cell lines that are deficient in the B7-1 expression empowers their antigen presentation potengy for activation of anti-tumor T cells.Our results suggested that repairing the deficiency of B7-1 co-stimulatory pathway in tumor cells might be a novel immunotherapeutic approach for human hematopoletic malignancies. | 
    
|---|---|
| AbstractList | Ojbective To define roles of B7-1 co-stimulation factor expressed in human malignant cell lines in mediating anti-tumor T cell immune responses.Methods Examining human leucocyte antigen(HLA)and B7 expressions on 8 human blood malignancies cell lines by flow cytometry.Transtecting B7-1 gene to B7-1 negative(B7^-)Raji and B7^- Jurkat cell lines by liposome,and comparing the potencies of blood malignant cell lines in the induction of T cell activation by examination of T cell cytokine mRNAs before and after transtection using semi-quantitative reverse transcription polymerase chain reaction(RT-PCR). Results High level of HLA Ⅰ and Ⅱ molecules were expressed in most human blood malignant cell lines examined,and the co-stimulatory factor B7-2 was also highly expressed.In contrast,another member of B7 family:B7-1 was either not axpressed or very limitedly expressed in most of these hematopoietic malignant cell lines.Most importantly,transfection of B7-1 gene to B7^-.Raji and B7^-.Jurkat cell lines made these cell lines better antigen presenting cells for stimulation of anti-tumor T cell activation,which was demonstrated by up regulation of expression of T cell cytokines IL-2,IL-4 and INF-γ mRNAs after incubation of these tumor cells with T cells for 24h.Conclusions B7 co-stimulation plays an important role in anti-tumor immunity.Transfection of B7-1 gene to the human hematopoietic malignant cell lines that are deficient in the B7-1 expression empowers their antigen presentation potengy for activation of anti-tumor T cells.Our results suggested that repairing the deficiency of B7-1 co-stimulatory pathway in tumor cells might be a novel immunotherapeutic approach for human hematopoletic malignancies. To define roles of B7-1 co-stimulation factor expressed in human malignant cell lines in mediating anti-tumor T cell immune responses. Examining human leucocyte antigen (HLA) and B7 expressions on 8 human blood malignancies cell lines by flow cytometry. Transfecting B7-1 gene to B7-1 negative (B7(-)) Raji and B7(-) Jurkat cell lines by liposome, and comparing the potencies of blood malignant cell lines in the induction of T cell activation by examination of T cell cytokine mRNAs before and after transfection using semi-quantitative reverse transcription polymerase chain reaction (RT-PCR). High level of HLA I and II molecules were expressed in most human blood malignant cell lines examined, and the co-stimulatory factor B7-2 was also highly expressed. In contrast, another member of B7 family: B7-1 was either not expressed or very limitedly expressed in most of these hematopoietic malignant cell lines. Most importantly, transfection of B7-1 gene to B7(-). Raji and B7(-). Jurkat cell lines made these cell lines better antigen presenting cells for stimulation of anti-tumor T cell activation, which was demonstrated by up regulation of expression of T cell cytokines IL-2, IL-4 and INF-gamma mRNAs after incubation of these tumor cells with T cells for 24 h. B7 co-stimulation plays an important role in anti-tumor immunity. Transfection of B7-1 gene to the human hematopoietic malignant cell lines that are deficient in the B7-1 expression empowers their antigen presentation potency for activation of anti-tumor T cells. Our results suggested that repairing the deficiency of B7-1 co-stimulatory pathway in tumor cells might be a novel immunotherapeutic approach for human hematopoietic malignancies. To define roles of B7-1 co-stimulation factor expressed in human malignant cell lines in mediating anti-tumor T cell immune responses.OBJECTIVETo define roles of B7-1 co-stimulation factor expressed in human malignant cell lines in mediating anti-tumor T cell immune responses.Examining human leucocyte antigen (HLA) and B7 expressions on 8 human blood malignancies cell lines by flow cytometry. Transfecting B7-1 gene to B7-1 negative (B7(-)) Raji and B7(-) Jurkat cell lines by liposome, and comparing the potencies of blood malignant cell lines in the induction of T cell activation by examination of T cell cytokine mRNAs before and after transfection using semi-quantitative reverse transcription polymerase chain reaction (RT-PCR).METHODSExamining human leucocyte antigen (HLA) and B7 expressions on 8 human blood malignancies cell lines by flow cytometry. Transfecting B7-1 gene to B7-1 negative (B7(-)) Raji and B7(-) Jurkat cell lines by liposome, and comparing the potencies of blood malignant cell lines in the induction of T cell activation by examination of T cell cytokine mRNAs before and after transfection using semi-quantitative reverse transcription polymerase chain reaction (RT-PCR).High level of HLA I and II molecules were expressed in most human blood malignant cell lines examined, and the co-stimulatory factor B7-2 was also highly expressed. In contrast, another member of B7 family: B7-1 was either not expressed or very limitedly expressed in most of these hematopoietic malignant cell lines. Most importantly, transfection of B7-1 gene to B7(-). Raji and B7(-). Jurkat cell lines made these cell lines better antigen presenting cells for stimulation of anti-tumor T cell activation, which was demonstrated by up regulation of expression of T cell cytokines IL-2, IL-4 and INF-gamma mRNAs after incubation of these tumor cells with T cells for 24 h.RESULTSHigh level of HLA I and II molecules were expressed in most human blood malignant cell lines examined, and the co-stimulatory factor B7-2 was also highly expressed. In contrast, another member of B7 family: B7-1 was either not expressed or very limitedly expressed in most of these hematopoietic malignant cell lines. Most importantly, transfection of B7-1 gene to B7(-). Raji and B7(-). Jurkat cell lines made these cell lines better antigen presenting cells for stimulation of anti-tumor T cell activation, which was demonstrated by up regulation of expression of T cell cytokines IL-2, IL-4 and INF-gamma mRNAs after incubation of these tumor cells with T cells for 24 h.B7 co-stimulation plays an important role in anti-tumor immunity. Transfection of B7-1 gene to the human hematopoietic malignant cell lines that are deficient in the B7-1 expression empowers their antigen presentation potency for activation of anti-tumor T cells. Our results suggested that repairing the deficiency of B7-1 co-stimulatory pathway in tumor cells might be a novel immunotherapeutic approach for human hematopoietic malignancies.CONCLUSIONSB7 co-stimulation plays an important role in anti-tumor immunity. Transfection of B7-1 gene to the human hematopoietic malignant cell lines that are deficient in the B7-1 expression empowers their antigen presentation potency for activation of anti-tumor T cells. Our results suggested that repairing the deficiency of B7-1 co-stimulatory pathway in tumor cells might be a novel immunotherapeutic approach for human hematopoietic malignancies. R73; Objective To define roles of B7-1 co-stimulation factor expressed in human malignant cell lines in mediating anti-tumor T cell immune responses. Methods Examining human leucocyte antigen (HLA) and B7 expressions on 8 human blood malignancies cell lines by flow cytometry. Transfecting B7-1 gene to B7-1 negative (B7*!-) Raji and B7*!- Jurkat cell lines by liposome, and comparing the potencies of blood malignant cell lines in the induction of T cell activation by examination of T cell cytokine mRNAs before and after transfection using semi-quantitative reverse transcription polymerase chain reaction (RT-PCR). Results High level of HLA Ⅰ and Ⅱ molecules were expressed in most human blood malignant cell lines examined, and the co-stimulatory factor B7-2 was also highly expressed. In contrast, another member of B7 family: B7-1 was either not expressed or very limitedly expressed in most of these hematopoietic malignant cell lines. Most importantly, transfection of B7-1 gene to B7*!-. Raji and B7*!-. Jurkat cell lines made these cell lines better antigen presenting cells for stimulation of anti-tumor T cell activation, which was demonstrated by up regulation of expression of T cell cytokines IL-2, IL-4 and INF-γ mRNAs after incubation of these tumor cells with T cells for 24 h. Conclusions B7 co-stimulation plays an important role in anti-tumor immunity. Transfection of B7-1 gene to the human hematopoietic malignant cell lines that are deficient in the B7-1 expression empowers their antigen presentation potency for activation of anti-tumor T cells. Our results suggested that repairing the deficiency of B7-1 co-stimulatory pathway in tumor cells might be a novel immunotherapeutic approach for human hematopoietic malignancies.  | 
    
| Author | 克晓燕 贾丽萍 王晶 王德炳 | 
    
| AuthorAffiliation | DepartmentofHematology,ThirdHospital,PekingUniversity,Beijing100083,China InstituteofBloodDiseaseResearch,People’sHospital,PekingUniversity,Beijing100083,China | 
    
| AuthorAffiliation_xml | – name: Department of Hematology, Third Hospital, Peking University, Beijing 100083, China%Institute of Blood Disease Research, People's Hospital, Peking University, Beijing 100083, China | 
    
| Author_xml | – sequence: 1 fullname: 克晓燕 贾丽萍 王晶 王德炳  | 
    
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/12667394$$D View this record in MEDLINE/PubMed | 
    
| BookMark | eNpF0EtOwzAQBmALgaAFroDMhl0kv2LHSyhPqYJNWUeOM0lTEruNE6qy4hCckJOQqhRWs5hv_hnNGB067-AAjVgsWBRLQQ_RiHApI6m1PkHjEBaEsDhW8hidUCal4lqM0GbWGhcKsF3lHfYFvlHfn18U29vnawzN0q-hDdi4rirB4WULAVxn9jirvc9xY-qqdIPBFuo64MK32AyB739uOz_Edn0ztGY7doaOClMHOP-tp-j1_m42eYymLw9Pk-tpZJkUXVSwPFM5JLnNlEmyDHSRQE6V1EZTYLHMrZHAhGCcCpkkxFAigBo5TOmYan6Krna5a-MK48p04fvWDRvTj7ltFowQTiihyT9ctn7VQ-jSpgrbU40D34dUcRpTJbbw4hf2WQN5umyrxrSbdP_VAVzugJ17V66qYWlm7FtR1ZAqyRUlnP8AIXiECg | 
    
| ClassificationCodes | R73 | 
    
| ContentType | Journal Article | 
    
| Copyright | Copyright © Wanfang Data Co. Ltd. All Rights Reserved. | 
    
| Copyright_xml | – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved. | 
    
| DBID | 2RA 92L CQIGP W91 ~WA CGR CUY CVF ECM EIF NPM 7X8 2B. 4A8 92I 93N PSX TCJ  | 
    
| DatabaseName | 维普期刊资源整合服务平台 中文科技期刊数据库-CALIS站点 维普中文期刊数据库 中文科技期刊数据库-医药卫生 中文科技期刊数据库- 镜像站点 Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Wanfang Data Journals - Hong Kong WANFANG Data Centre Wanfang Data Journals 万方数据期刊 - 香港版 China Online Journals (COJ) China Online Journals (COJ)  | 
    
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic  | 
    
| DatabaseTitleList | MEDLINE MEDLINE - Academic  | 
    
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database  | 
    
| DeliveryMethod | fulltext_linktorsrc | 
    
| Discipline | Medicine | 
    
| EISSN | 2542-5641 | 
    
| EndPage | 84 | 
    
| ExternalDocumentID | zhcmj200301018 12667394 7637103  | 
    
| Genre | Research Support, Non-U.S. Gov't Journal Article  | 
    
| GrantInformation_xml | – fundername: National Nature Science Foundation funderid: (39770328)  | 
    
| GroupedDBID | --- -05 -0E -SE -S~ .55 .GJ 29B 2B. 2C~ 2RA 2WC 3V. 40I 53G 5GY 5RE 5VR 5VS 6J9 7X7 88E 8FI 8FJ 92F 92I 92L 92M 93N 93R 9D9 9DE AABQG AAHPQ AALRV AAPBV ABASU ABDIG ABFLS ABUWG ABXLX ACGFO ACGFS ADGIM ADPDF ADRAZ AENEX AFDTB AFKRA AFUIB AHMBA AHVBC AJIOK ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR BBAFP BENPR BPHCQ BVXVI C1A CAJEE CAJUS CCEZO CDYEO CHBEP CIEJG CQIGP CW9 CXBCV DIK DIWNM EBS EJD F5P FA0 FRP FYUFA GQDEL GROUPED_DOAJ GX1 H13 HYE IAO IHR IHW IKREB INH INR IPNFZ ITC JUIAU KQ8 L7B M1P M48 N95 OK1 OLW OPUJH OVD OVDNE OVEED OXXIT P2P P6G PIMPY PQEST PQQKQ PQUKI PROAC PSQYO PV9 Q-- Q-4 R-E RIG RNS RPM RT5 RZL S.. T8U TCJ TEORI TGQ TR2 TSPGW U1F U1G U5E U5O UKHRP W2D W91 WFFXF X7J X7M XSB ZA5 ZGI ZXP ~WA 0R~ AAAAV AAIQE AASCR ABCQX ABVCZ ACILI ACXJB ADGGA ADHPY AHQNM AINUH AJCLO AJNWD AJZMW AKCTQ ALIPV ALKUP AMNEI AOHHW BQLVK CCPQU CGR CUY CVF ECM EEVPB EIF FCALG GNXGY HLJTE HMCUK NPM RLZ 7X8 OVT 4A8 ABZZY AFBFQ AOQMC PHGZM PHGZT PMFND PSX  | 
    
| ID | FETCH-LOGICAL-c264t-f2db7de8dcb7a8bbe9f8ed1769a91e256dca6e24423146880a104e1a6b7d95193 | 
    
| ISSN | 0366-6999 | 
    
| IngestDate | Thu May 29 04:01:06 EDT 2025 Fri Sep 05 07:00:02 EDT 2025 Wed Feb 19 01:41:36 EST 2025 Thu Nov 24 20:30:55 EST 2022  | 
    
| IsPeerReviewed | true | 
    
| IsScholarly | true | 
    
| Issue | 1 | 
    
| Keywords | B7 tumor immunity gene transfection  | 
    
| Language | English | 
    
| LinkModel | OpenURL | 
    
| MergedId | FETCHMERGED-LOGICAL-c264t-f2db7de8dcb7a8bbe9f8ed1769a91e256dca6e24423146880a104e1a6b7d95193 | 
    
| Notes | 11-2154/R R730.51 R733 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23  | 
    
| PMID | 12667394 | 
    
| PQID | 73151748 | 
    
| PQPubID | 23479 | 
    
| PageCount | 7 | 
    
| ParticipantIDs | wanfang_journals_zhcmj200301018 proquest_miscellaneous_73151748 pubmed_primary_12667394 chongqing_backfile_7637103  | 
    
| PublicationCentury | 2000 | 
    
| PublicationDate | 2003 2003-Jan 20030101  | 
    
| PublicationDateYYYYMMDD | 2003-01-01 | 
    
| PublicationDate_xml | – year: 2003 text: 2003  | 
    
| PublicationDecade | 2000 | 
    
| PublicationPlace | China | 
    
| PublicationPlace_xml | – name: China | 
    
| PublicationTitle | Chinese medical journal | 
    
| PublicationTitleAlternate | Chinese Medical Journal | 
    
| PublicationTitle_FL | CHINESE MEDICAL JOURNAL | 
    
| PublicationYear | 2003 | 
    
| Publisher | Department of Hematology, Third Hospital, Peking University, Beijing 100083, China%Institute of Blood Disease Research, People's Hospital, Peking University, Beijing 100083, China | 
    
| Publisher_xml | – name: Department of Hematology, Third Hospital, Peking University, Beijing 100083, China%Institute of Blood Disease Research, People's Hospital, Peking University, Beijing 100083, China | 
    
| SSID | ssj0025576 | 
    
| Score | 1.6221672 | 
    
| Snippet | Ojbective To define roles of B7-1 co-stimulation factor expressed in human malignant cell lines in mediating anti-tumor T cell immune responses.Methods... To define roles of B7-1 co-stimulation factor expressed in human malignant cell lines in mediating anti-tumor T cell immune responses. Examining human... To define roles of B7-1 co-stimulation factor expressed in human malignant cell lines in mediating anti-tumor T cell immune responses.OBJECTIVETo define roles... R73; Objective To define roles of B7-1 co-stimulation factor expressed in human malignant cell lines in mediating anti-tumor T cell immune responses. Methods...  | 
    
| SourceID | wanfang proquest pubmed chongqing  | 
    
| SourceType | Aggregation Database Index Database Publisher  | 
    
| StartPage | 78 | 
    
| SubjectTerms | Antigen Presentation Antigens, CD - analysis B7-1 Antigen - analysis B7-1 Antigen - physiology B7-2 Antigen B7-1转染 cDNA Cytokines - genetics Flow Cytometry Hematologic Neoplasms - immunology HLA-DR7 Antigen - physiology Humans K562 Cells Lymphocyte Activation Membrane Glycoproteins - analysis RNA, Messenger - analysis T-Lymphocytes - immunology Transfection U937 Cells 恶性血液病细胞系 抗原提呈 抗肿瘤T-细胞  | 
    
| Title | Transfection of B7—1 cDNA empowers antigen presentation of blood malignant cells for activation of anti—tumor T cells | 
    
| URI | http://lib.cqvip.com/qk/85656X/20031/7637103.html https://www.ncbi.nlm.nih.gov/pubmed/12667394 https://www.proquest.com/docview/73151748 https://d.wanfangdata.com.cn/periodical/zhcmj200301018  | 
    
| Volume | 116 | 
    
| hasFullText | 1 | 
    
| inHoldings | 1 | 
    
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 2542-5641 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0025576 issn: 0366-6999 databaseCode: KQ8 dateStart: 20000101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2542-5641 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0025576 issn: 0366-6999 databaseCode: DOA dateStart: 20000101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 2542-5641 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0025576 issn: 0366-6999 databaseCode: GX1 dateStart: 20000101 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research  | 
    
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELbQHhAXxJsuLx_wKcqqbhI_jhsaWCHtnrpSb5HjOF2BmgJtD-yJH8Ev5JcwYydpVlohQKqiyPK4qeer8409D0LeyrqaOs3TeKZ4E6eVqGKjMh3r2mmR8mntEgxOPr8QZ5fpx2W2PJzo-uiSXXVir2-NK_kfrUIb6BWjZP9Bs8Og0AD3oF-4gobh-nc69qzT2Z715bL3XUh5ZOcXpxEmnsIyaBFMIObdxJwAfbiRF_GO69Ea2PgKXWIi3MjfBtdK21c-874CID8MvtuvocMidB7TW6zGDeOHE_tDXopeq6zImIJPzgrBtGY6YYVkSjKdRaxQLE9ZXrACrnA_xxY9ZWoe-V7FQS4X46YMhfCnQ8uM5cmNjYxktNIlQsRCh0pJJ863geEKVrIIWbGGpTrEZd7AZFh4Qx2g_hWeHt5ug88hLKTApjAvLHAyNNM_LAdnILCrZHeqHR4EM21cbdrVV-APt9kePsSrbUy7GrGRxQNyvzMj6GnAxENyx7WPyN3zzlHiMfk-hgbdNDSXv3785BRBQXtQ0A4UdAwK7OxBQQdQUK9nCqCgB1BgP5SHYT0c6CJ0e0Iu3xeLd2dxV2UjtkCGd3EzqytZO1XbShpVVU43ytVcCm00d8CIa2uEAxYIlkAqYLk3YME7bgRIaeT_T8lRu2ndc0KN1tbASMZxC_9zo11aV41VGCkkwTCfkONhVoGl2c-Ye6zsFDMhb_ppLmGJw0c2rdvst6VMOOZTVxPyLMx--SVkYin5DKvW6hRkO3WUHbC35fWVXX-aeZN_ytXxn776BbnnfTT9ztpLcrT7tnevgGvuqtceJr8BZ6t6Wg | 
    
| linkProvider | Geneva Foundation for Medical Education and Research | 
    
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Transfection+of+B7%E2%80%941+cDNA+empowers+antigen+presentation+of+blood+malignant+cells+for+activation+of+anti%E2%80%94tumor+T+cells&rft.jtitle=Chinese+medical+journal&rft.au=%E5%85%8B%E6%99%93%E7%87%95+%E8%B4%BE%E4%B8%BD%E8%90%8D+%E7%8E%8B%E6%99%B6+%E7%8E%8B%E5%BE%B7%E7%82%B3&rft.date=2003&rft.issn=0366-6999&rft.eissn=2542-5641&rft.volume=116&rft.issue=1&rft.spage=78&rft.epage=84&rft.externalDocID=7637103 | 
    
| thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F85656X%2F85656X.jpg http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fzhcmj%2Fzhcmj.jpg  |